Prevention of adenoviral acute respiratory disease in army recruits: Cost-effectiveness of a military vaccination policy

American Journal of Preventive Medicine

Volumn 14, Issue 3, 1998, Pages 168-175

  Howell, M René ^a   Nang, Major Roberto N ^b   Gaydos, Charlotte A ^a   Gaydos, Colonel Joel C ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b U S ARMY CENTER FOR HEALTH PROMOTION AND PREVENTIVE MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ARMY; ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE POLICY; HUMAN; INFECTION PREVENTION; RESPIRATORY TRACT INFECTION; SOLDIER; VIRUS INFECTION;

ACUTE DISEASE; ADENOVIRUS INFECTIONS, HUMAN; COST SAVINGS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HEALTH CARE COSTS; HUMANS; INCIDENCE; MALE; MILITARY PERSONNEL; RESPIRATORY TRACT INFECTIONS; SEASONS; SENSITIVITY AND SPECIFICITY; UNITED STATES; VACCINATION;

EID: 0031897116     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-3797(97)00064-0     Document Type: Article

References (12)

1. Dudding BA, Top FA, Winter PE, Buescher EL, Lamson TH, Leibovitz A. Acute respiratory disease in military trainees the adenovirus surveillance program 1966-1971 . Am J Epidemiol. 97:1973;187-198.
2. Van Der Veen J, Giok Oei K, Abarbanel MFW. Patterns of infections with adenovirus types 4, 7 and 21 in military recruits during a 9-year survey. J Hyg Camb. 67:1969;255-268.
3. Gaydos CA, Gaydos JC. Adenovirus vaccines in the U.S. military. Mil Med. 160:1995;300-304.
4. Collis PB, Dudding BA, Winter PE, Russel PK, Buescher EL. Adenovirus vaccines in military recruit populations a cost-benefit analysis . JID. 128:1973;745-752.
5. Medical Surveillance Monthly Report. Adenovirus outbreak, basic trainees, Ft. Jackson, SC [ed. note]. Aberdeen Proving Ground, MD: U.S. Army Center for Health Promotion and Preventive Medicine, 1995;1:10.
6. Takafuji ET, Gaydos JC, Allen RG, Top FH. Simultaneous administration of live enteric-coated adenovirus types 4, 7, and 21 vaccines safety and immunogenicity . JID. 140:1979;48-53.
7. Top FH, Grossman RA, Bartelloni PJ, Segal HE, Dudding BA, Russell PK, Buescher EL. Immunization with live types 7 and 4 adenovirus vaccines I. Safety, infectivity, anitigenicity, and potency of adenovirus type 7 vaccine in humans. JID. 124:1971;148-154.
8. Top FH, Buescher EL, Bancroft WH, Russell PK. Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. JID. 124:1971;155-160.
9. Chen RT, Orenstein WA. Epidemiologic methods in immunization programs. Epidemiol Rev. 18:1996;99-117.
10. Brundage JF, Scott RM, Lednar WM, Sith DW, Miller RN. Building-associated risk of febrile acute respiratory diseases in Army trainees. JAMA. 259:1988;2108-2112.
11. Nichol KL, Lind A, Margolis K, Murdoch M, MacFadden R, Hauge M, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med. 333:1995;889-893.
12. Bartlett J. Update in infectious diseases. Ann Intern Med. 126:1997;48-56.